Erowid Monthly
On January 18th, Erowid joined the Internet protest of proposed U.S. SOPA/PIPA legislation by blacking out the site for a full day. These laws would allow blocking and blacklisting of entire websites that have been accused of copyright violation: an attempt to bypass the 1st Amendment with a legal loophole. Thanks to everyone for your patience and support while Erowid was down for this important protest.

Unfortunately, following the death of our largest funder a few months ago, we need to increase the amount of fundraising we do until we can raise an additional $60,000 in pledges for 2012. If you know donors or foundations that support the type of work Erowid does, please let us know. Erowid Center, a 501(c)(3) nonprofit, is in deep need of new major contribution sources. Also, if you or someone you know works for a corporation with a charitable giving plan, many such companies match donations made to nonprofits, doubling any money contributed.

We need your help finding new sources of non-advertising funding, especially in the $5,000-$50,000 per year range. Please bear with us as we search out these crucial new funders over the next few months.

Visit or email us at

Our best,
Earth, Fire, and the Erowid crew
Drug Geek Factlet
The U.S. Congress is moving towards controlling CB1 cannabinoid receptor agonists ("cannabimimetic agents") as a group using wording that would add to Schedule I even substances with no psychoactive or recreational properties, despite promising medical research into these compounds. H.R. 1254, the Synthetic Drug Control Act of 2011, was approved by the U.S. House in December but has not yet been approved by the Senate. Along with attempting to ban CB1-agonists based on "binding studies and functional assays", the bill also seeks to prohibit a number of cathinone and phenethylamine substances that have seen some recreational use over the last few years, such as 4-methylmethcathinone, MDPV, 2C-E, and others.
Progress Not Prisons
Canadian Students for Sensible Drug Policy National Conference
(March 2-4, 2012) in Calgary, Alberta
Latest Additions
Information about this relatively new dissociative psychedelic--which has some similarities with PCP and ketamine--including dosage, effects, legal status, images, and more.
The earliest interview with Terence ever published. Trip back in time to 1983, to revisit riveting rants on the logos, psilocybin-induced entity contact, and the evolution of human consciousness.
We've recently added a vault for the Chilean psychiatrist Claudio Naranjo, as well as for Erowid's co-founders, Fire and Earth.
Erowid columnist The Teafaerie returns after a year-long hiatus from writing, with a recommendation for tempering enthusiasm with caution. Both when discussing drugs and when consuming them, it is important to remember that everyone's mileage may vary.
Crew Notes
Earlier this month, Earth and Fire received and accepted an invitation to join the Advisory Council of Students for Sensible Drug Policy. We are honored to support their valuable project.
From the Vaults
In a parody of 'Chick Tracts', this booklet covers Albert Hofmann's discovery of LSD and highlights of its history. A subsequent issue from Trick Publications covered MDMA and Alexander Shulgin. For more psychoactives-related humor, visit the Humor Vault.
More New Content
  1. Drugs of Abuse: A DEA Resource Guide (2011 Edition)
    Describes the parameters of the Controlled Substances Act and scheduling system, federal tracking penalties, and drug classes, illustrated with "precise photographs shot to scale".
  2. Amphetamine: A European Union Perspective in the Global Context
    Patterns and trends in the production and trafficking of amphetamine in European countries are examined in this report. Amphetamine is the most widely consumed stimulant drug in the EU after cocaine.
  3. Psychozoic Press #5 (PDF)
    This scan of the fifth issue of Psychozoic Press, from 1983, features articles on psychedelic churches, an Amanita muscaria experience report, info on neurotransmitters & MAO inhibitors, and more.
Ecstasy Data
EcstasyData is a project of Erowid Center that conducts laboratory testing of street Ecstasy tablets and publishes these and other test results online.
Donate Or Become A Member
If you find Erowid a useful resource and are interested in supporting its future development, please consider donating or becoming a member. Donations to Erowid Center are tax-deductible in the United States.
List Subscription Information
  • To UNSUBSCRIBE - send an empty email to:
  • To SUBSCRIBE - send an empty email to: